Knollwood Investment Advisory’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.26M Hold
5,800
0.33% 71
2025
Q4
$3.92M Hold
5,800
0.37% 60
2025
Q3
$3.71M Hold
5,800
0.33% 67
2025
Q2
$3.11M Hold
5,800
0.3% 80
2025
Q1
$2.44M Hold
5,800
0.27% 97
2024
Q4
$2.4M Hold
5,800
0.25% 101
2024
Q3
$2.93M Hold
5,800
0.31% 80
2024
Q2
$2.83M Buy
5,800
+4,900
+544% +$2.46M 0.31% 76
2024
Q1
$486K Hold
900
0.09% 147
2023
Q4
$500K Buy
+900
New +$423K 0.1% 141

Other funds holding IDXX

Knollwood Investment Advisory's IDXX Position: Q1 2026 in Review

Knollwood Investment Advisory held its Idexx Laboratories (IDXX) position steady in Q1 2026 at 5,800 shares worth $3.26M. The position accounts for 0.33% of the portfolio, ranked #71.

Knollwood Investment Advisory first reported a position in IDXX in Q4 2023 and has held it in 10 quarters since. The position peaked at $3.92M in Q4 2025. 1,314 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • Knollwood Investment Advisory held 5,800 shares of Idexx Laboratories worth $3.26M as of Q1 2026.
  • Knollwood Investment Advisory left its Idexx Laboratories share count unchanged in Q1 2026.
  • Idexx Laboratories made up 0.33% of Knollwood Investment Advisory's portfolio in Q1 2026, its #71 holding.
  • Knollwood Investment Advisory first reported a position in Idexx Laboratories in Q4 2023 and has held it in 10 quarters since.
  • Knollwood Investment Advisory's Idexx Laboratories position peaked at $3.92M in Q4 2025.
  • 1,314 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on Knollwood Investment Advisory's 13F filing for Q1 2026, filed 14 May 2026.